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Tuesday, February 18, 2014 563aaffect of OM on the actin-activated power-stroke. These results show that OM
has a direct effect on the power-stroke structural transition that drives force
generation in muscle, thus providing structural insight into the mechanism of
this new potential therapy for heart failure. Our results also highlight the utility
of structure-based time-resolved FRET and EPR assays for the discovery and
characterization of allosteric enzyme modulators.
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It has been demonstrated that the phosphorylation of the RLC can also aid in
the attachment of myosin heads to actin. Moreover, it has been demonstrated
that phosphorylation of the RLC is altered during heart failure progression.
Here we examined the role of the RLC, and its phosphorylation, on the
motility of a and b Myosin. We characterized the strain dependent kinetics
of both myosins by analyzing the dependence of velocity on load using
increasing amounts of a-actinin up to 10 mg/ml. As expected, a-myosin,
both phosphorylated and dephosphorylated, had a faster actin sliding velocity
than b-myosin over the majority of a-actinin concentrations, while phosphor-
ylation of the b-myosin had no significant impact on the actin sliding velocity.
Interestingly, although phosphorylation of
a-myosin significantly reduced the un-
loaded sliding velocity it, increased veloc-
ity under loaded conditions (See Figure).
These results suggest that the phosphory-
lation of the RLC acts at the molecular
level to stiffen the lever arm of myosin
aiding in both myosin head attachment
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Familial Hypertrophic Cardiomyopathy (FHC) is characterized by left ven-
tricular hypertrophy that can often be preceded by diastolic dysfunction. The
clinical presentation of the disease varies from asymptomatic to progressive
heart failure to sudden cardiac death. FHC is caused by mutations in genes
that encode for all major sarcomeric proteins. There are 12 known FHC-
linked mutations in the myosin regulatory light chain (RLC). The RLC
mechanically stabilizes the myosin lever arm, which is crucial to myosin’s
ability to transmit contractile force. Two FHC mutations, N47K and R58Q,
located in the RLC Ca2þ-Mg2þ site have previously been shown to reduce
actin filament velocity under load, stemming from a more compliant lever
arm (Greenberg et al., PNAS add details 2010). In contrast, phosphorylation
of the RLC can impart stiffness to the myosin lever arm. We hypothesized
that phosphorylation of the N47K-RLC may mitigate distinct mutation-
induced structural and functional abnormalities. To generate mutant
b-myosin, native pig RLC was depleted from porcine cardiac myosin
heavy chain and reconstituted with mutant N47K or wild-type human
RLC. In the work presented here, in vitro motility assays were utilized to
investigate the effects of RLC phosphorylation on the N47K-RLC mutant
phenotype in the presence of an a-actinin frictional load. Consistent with
previous findings, myosin bearing the N47K mutation reduced actin sliding
velocity compared to WT when incubated with a-actinin, resulting in a 25%
reduction in force production. Phosphorylation of N47K mutant myosin
increased sliding velocity and restored force production to WT values.
These results point to RLC phosphorylation as a potential target to amelio-
rate the FHC RLC phenotype at the molecular level. Supported by AHA-
12PRE11910009 (AK), 10POST3420009 (PM), NIH- HL071778 &
HL108343 (DSC) and HL077280 (JM).
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Cardiac and skeletal muscle myosins have the central role in contraction
transducing ATP free energy into the mechanical work of moving actin intransduction/mechanical coupling. Inheritable cardiomyopathies are more
frequently linked to myosin mutations than other sarcomeric proteins. Hered-
itary skeletal myopathies linked to myosin are less common. They lead to
muscle weakness or affect myosin isoforms expressed during development
leading to arthrogryposis syndromes. Myosin has a motor domain containing
ATP and actin binding sites and light chains stabilized lever-arm that un-
dergoes rotation impelling bound actin. The lever-arm converts torque gener-
ated in the motor into linear displacement (step-size). Relative myosin and
actin filament sliding is modeled in vitro with a motility assay quantitating
actin filament translation over a myosin coated surface. A novel quantum
dot super-resolution in vitro motility assay confirmed a 5 nm step-size for
fast skeletal myosin while b cardiac myosin (bMys) had multiple unitary
steps, most frequently 5 and 8 nm, and a rare 3 nm displacement. The myosin
lever-arm is stabilized by bound essential and regulatory light chains (ELC
and RLC). RLC phosphorylation at S15 is linked to modified lever-arm me-
chanical characteristics contributing to disease and to myosin filament based
contraction regulation. We have studied the effect of RLC phosphorylation on
the step-size of porcine bMys. Phosphorylated bMys has ~85% of the myosin
phosphorylated. We find RLC phosphorylation causing the distribution of
longest step increasing from 37% to 71%. This dramatic re-distribution of
step-sizes provides significant gain in average step-size. The results indicate
a mechanism for contraction regulation by step-size adaptation using post-
translational modification of the myosin filament via RLC phosphorylation.
Research supported by R01AR049277, R01HL095572 and the Mayo
Foundation.
2847-Pos Board B539
A13T Mutation in the Regulatory Light Chain Associated with Cardiac
Hypertrophy Imposes Differences in Kinetics of Healthy and Diseased
Ventricles
Janhavi Nagwekar1, Divya Duggal1, Krishna Midde2, Priya Muthu3,
W. Huang3, Rafal Fudala1, Ignacy Gryczynski1, Zygmunt Gryczynski1,
Danuta Szczesna-Cordary3, Julian Borejdo1.
1University of North Texas Health Science Center (UNTHSC), Fort Worth,
TX, USA, 2University of San Diego, San Diego, CA, USA, 3Miller School of
Medicine, University of Miami, Miami, FL, USA.
The effect of A13T (alanine to threonine) hypertrophic cardiomyopathy mu-
tation in the myosin regulatory light chain (RLC) was examined in working
ex-vivo myofibrils from the hearts of transgenic (Tg) mice. Myofibrillar
actin was labeled with a fluorescent dye. A small volume within the
I-band (?1 fL), containing on average 3-4 actin molecules, was observed
by confocal microscopy. The myofibrils were cross-linked with EDC
[1-ethyl-3-[3-(dimethylamino) propyl] carbodiimide] to prevent shortening
during muscle contraction. Working myosin cross-bridges cause actin to un-
dergo the cyclic fluctuations of orientation, which were measured by
recording the polarization of fluorescent light emitted by the actin-bound
fluorophore. The autocorrelation function of fluctuations of polarized fluo-
rescence contains information about the kinetics of motion, which were
found to be very different for left vs. right ventricles. The center of distri-
bution of orientations of transition dipoles during contraction were very
different for the Wild Type (WT) and mutated (MUT) ventricles, but their
skewness and kurtosis were the same. The distribution of orientations
measured in contracting WT myofibrils could be fitted by at least two
Gaussians reflecting a pre- and post power stroke states of the myosin
cross-bridges. However, the distribution of MUT myofibrils showed only
one Gaussian relationship suggesting that the hypertrophic phenotype asso-
ciated with the A13T-RLC mutation might be characterized by a loss of the
pre-power stroke state.
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Cross-bridge (XB) kinetics and the degree of order were examined in con-
tracting myofibrils from the ex-vivo left ventricles of transgenic (Tg) mice
expressing Familial Hypertrophic Cardiomyopathy (FHC) Regulatory Light
Chain (RLC) mutation K104E. Since the kinetics and degree of order are
best studied when an individual XB makes a significant contribution to the
